67 phenotypes from 8 alleles in 9 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Bcl11bm1Jpk/Bcl11btm1Jpk involves: BALB/c * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj	abnormal ameloblast morphology	J:199312
	abnormal incisor morphology	J:199312
	abnormal tooth development	J:199312
	decreased birth body size	J:199312
	decreased birth weight	J:199312
	lethality at weaning, complete penetrance	J:199312
	long incisors	J:199312
	midface hypoplasia	J:199312
	short basicranium	J:199312
	short maxilla	J:199312
Bcl11btm1.1(KOMP)Vlcg/Bcl11b+ B6N(Cg)-Bcl11btm1.1(KOMP)Vlcg/J	abnormal bone structure	J:211773
	increased bone mineral content	J:211773
	increased fasting circulating glucose level	J:211773
	increased vertical activity	J:211773
Bcl11btm1.1(KOMP)Vlcg/Bcl11btm1.1(KOMP)Vlcg B6N(Cg)-Bcl11btm1.1(KOMP)Vlcg/J	abnormal eyelid fusion	J:211773
	abnormal facial morphology	J:211773
	preweaning lethality, complete penetrance	J:211773
Bcl11btm1.1Leid/Bcl11btm1.1Leid Tg(KRT14-cre)1Ipc/0 involves: C57BL/6 * SJL	abnormal epidermal layer morphology	J:147182
	abnormal epidermis stratum corneum morphology	J:147182
	impaired skin barrier function	J:147182
Bcl11btm1.2Leid/Bcl11btm1.2Leid involves: C57BL/6 * SJL	abnormal corneocyte morphology	J:147182
	abnormal epidermal layer morphology	J:147182
	abnormal epidermis stratum corneum morphology	J:147182
	abnormal epidermis stratum granulosum morphology	J:147182
	abnormal suckling behavior	J:147182
	absent T cells	J:147182
	eyelids open at birth	J:147182
	impaired skin barrier function	J:147182
	neonatal lethality, complete penetrance	J:147182
	thin epidermis	J:147182
	thymus hypoplasia	J:147182
Bcl11btm1.2Leid/Bcl11btm1.2Leid involves: ICR	abnormal ameloblast differentiation	J:146765
	abnormal ameloblast morphology	J:146765
	abnormal enamel cord morphology	J:146765
	abnormal enamel knot morphology	J:146765
	abnormal incisor morphology	J:146765
	abnormal odontoblast morphology	J:146765
	abnormal outer dental epithelium morphology	J:146765
	abnormal stellate reticulum morphology	J:146765
	abnormal tooth development	J:146765
	small incisors	J:146765
	small molars	J:146765
Bcl11btm1Avram/Bcl11btm1Avram Tg(Cd4-cre)1Cwi/? involves: 129 * C57BL/6 * DBA/2	abnormal leukocyte morphology	J:128515
	abnormal positive T cell selection	J:128515
	abnormal thymocyte activation	J:128515
	decreased CD4-positive, alpha-beta T cell number	J:128515
	decreased CD8-positive, alpha-beta T cell number	J:128515
	decreased double-negative T cell number	J:128515
	decreased double-positive T cell number	J:128515
	enlarged mesenteric lymph nodes	J:128515
	increased B cell number	J:128515
	increased dendritic cell number	J:128515
	increased gamma-delta T cell number	J:128515
	increased NK cell number	J:128515
	increased spleen weight	J:128515
	spleen hyperplasia	J:128515
	thymus hypoplasia	J:128515
Bcl11btm1Jpk/Bcl11btm1Jpk involves: BALB/c * C57BL/6 * CBA	abnormal T cell differentiation	J:83651
	abnormal T cell morphology	J:83651
	abnormal T cell receptor beta chain V(D)J recombination	J:83651
	abnormal thymus cortex morphology	J:83651
	abnormal thymus medulla morphology	J:83651
	absent gastric milk in neonates	J:83651
	absent thymus corticomedullary boundary	J:83651
	decreased double-positive T cell number	J:83651
	eyelids open at birth	J:83651
	increased CD8-positive, alpha-beta T cell number	J:83651
	increased double-negative T cell number	J:83651
	increased thymocyte apoptosis	J:83651
	neonatal lethality, complete penetrance	J:83651
	thymus hypoplasia	J:83651
Bcl11btm1Peli/Bcl11btm1Peli Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+ involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6J	abnormal NK cell differentiation	J:161373
	decreased metastatic potential	J:161373
Bcl11btm2.1Jpk/Bcl11b+ Tg(Cd4-cre)1Cwi/0 involves: C57BL/6 * C57BL/6J * DBA/2	normal immune system phenotype	J:210122
Bcl11btm2.1Jpk/Bcl11b+ Tg(Lck-cre)1Jtak/0 involves: C57BL/6	abnormal cell cycle	J:210122
	abnormal T cell number	J:210122
	decreased CD4-positive, alpha-beta T cell number	J:210122
	decreased CD8-positive, alpha-beta T cell number	J:210122
	decreased double-positive T cell number	J:210122
	decreased thymocyte number	J:210122
	increased double-negative T cell number	J:210122
	increased lymphoma incidence	J:210122